Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders (Q3911376): Difference between revisions

@@ Property / EU contribution @@
-,593,115.942 EuroAmount 3,593,115.942 Euro
Unit Euro
-Amount
+,593,115.942 Euro
-Unit
+Euro
@@ Property / EU contribution: 3,593,115.942 Euro / rank @@
-Preferred rank
@@ Property / EU contribution: 3,593,115.942 Euro / qualifier @@
-exchange rate to Euro: 0.00276521 EuroAmount 0.00276521 Euro
Unit Euro
-Amount
+.00276521 Euro
-Unit
+Euro
@@ Property / EU contribution: 3,593,115.942 Euro / qualifier @@
-point in time: 3 December 2021Timestamp +2021-12-03T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2021-12-03T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After

Revision as of 23:22, 14 December 2021

Project Q3911376 in Hungary

Language	Label	Description	Also known as
English	Chimeric antigen receptor T-cell (CAR-T) cell therapy in Hungary in paediatric acute lymphoblastic leukaemia (ALL) and adult diffuse large B-cell lymphoma (DLBCL) disorders	Project Q3911376 in Hungary